Diakron Pharmaceuticals   Report issue

For profit Phase 1
Founded: Morris Plains NJ United States (1998)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2011
NCT01347203
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

dpoc-4088 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 1)

Thrombosis (Phase 1)

Venous Thrombosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1